2002 NAICS Definitions
325413 In-Vitro Diagnostic Substance Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
Cross-References. Establishments primarily engaged in manufacturing in-vivo diagnostic substances are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.
| Go to: | No change 1997 to 2002 | 2002 NAICS to 1987 SIC | 1997 Economic Census | Bridge Between 1997 NAICS and SIC |
| 2002 NAICS | 1997 NAICS | 1987 SIC | Corresponding Index Entries |
|---|---|---|---|
| 325413 | 325413 | 2835 | Blood derivative in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Blood glucose test kits manufacturing |
| 325413 | 325413 | 2835 | Coagulation in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Cytology and histology in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Diagnostic substances, in-vitro, manufacturing |
| 325413 | 325413 | 2835 | Enzyme and isoenzyme in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Hematology in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | HIV test kits manufacturing |
| 325413 | 325413 | 2835 | Hormone in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | In-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Microbiology, virology, and serology in-vitro diagnostic substances manufacturing |
| 325413 | 325413 | 2835 | Pregnancy test kits manufacturing |
| 325413 | 325413 | 2835 | Viral in-vitro diagnostic test substances manufacturing |
